{"id":"W4231682820","doi":"10.17925/use.2014.10.02.130","title":"The Future of Combination Therapies of Insulin with a Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes – Is it Advantageous?","year":2014,"lang":"en","type":"article","venue":"US Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Type 2 diabetes; Insulin; Combination therapy; Diabetes mellitus; Glucagon-like peptide 1 receptor; Internal medicine; Glucagon-like peptide-1; Endocrinology; Pharmacology; Receptor; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002863656,0.000575473,0.001149966,0.0007360998,0.0003610954,0.001533356,0.000792194,0.002172852,0.00265539],"category_scores_gemma":[0.002488322,0.0002003895,0.0007809965,0.0004605252,0.001228595,0.003855829,0.0006280775,0.005370444,0.001243222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006198682,"about_ca_system_score_gemma":0.0006453229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002831333,"about_ca_topic_score_gemma":0.001076768,"domain_scores_codex":[0.998998,0.0004683251,0.00009726245,0.00006920185,0.0003106592,0.00005654472],"domain_scores_gemma":[0.9984433,0.0009376057,0.0001458187,0.00004428444,0.0002987024,0.0001302953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0006745835,0.0002303136,0.0004712456,0.002999368,0.0001670278,0.0008670236,0.000205836,0.0003380978,0.001911572,0.01938602,0.1527079,0.8200409],"study_design_scores_gemma":[0.0001030202,0.0004985032,0.0006927905,0.001312096,0.0001012996,0.002572867,0.0001786936,0.0002406652,0.0003407613,0.009120249,0.9848024,0.00003670781],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008037736,0.9354529,0.0007896161,0.04395862,0.01534769,0.000008187172,0.00001029608,0.00002709328,0.003601853],"genre_scores_gemma":[0.007603333,0.9217851,0.003075504,0.02532466,0.03808543,0.00002863557,0.00002568079,0.00002864342,0.004043038],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002863656,"threshold_uncertainty_score":0.01514465,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007451804776659725,"score_gpt":0.2450223806573442,"score_spread":0.2375705758806845,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}